|
|
||||||||||
|
J Am Coll Cardiol, 2003; 42:1454-1459, doi:10.1016/S0735-1097(03)01042-8 © 2003 by the American College of Cardiology Foundation |





* Scripps Memorial Hospital, La Jolla, California, USA
Riverside Methodist Hospital, Columbus, Ohio, USA
St. Luke's Presbyterian Hospital, Milwaukee, Wisconsin, USA
Genesis Medical Center, Davenport, Iowa, USA
|| Lancaster General Hospital, Lancaster, Pennsylvania, USA
¶ University of California San Francisco Medical Center, San Francisco, California, USA
# The Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA
** Duke University School of Medicine, Durham, North Carolina, USA

Guidant Corporation, St. Paul, Minnesota, USA
* Reprint requests and correspondence: Dr. Steven L. Higgins, Scripps Regional Cardiac Arrhythmia Center, 9888 Genesee Ave., La Jolla, California 92038-0028, USA.
EPDocHiggins{at}msn.com
OBJECTIVES: This study was conducted to assess the safety and effectiveness of cardiac resynchronization therapy (CRT) when combined with an implantable cardioverter defibrillator (ICD).
BACKGROUND: Long-term outcome of CRT was measured in patients with symptomatic heart failure (HF), intraventricular conduction delay, and malignant ventricular tachyarrhythmias (ventricular tachycardia/ventricular fibrillation [VT/VF]) requiring therapy from an ICD.
METHODS: Patients (n = 490) were implanted with a device capable of providing both CRT and ICD therapy and randomized to CRT (n = 245) or control (no CRT, n = 245) for up to six months. The primary end point was progression of HF, defined as all-cause mortality, hospitalization for HF, and VT/VF requiring device intervention. Secondary end points included peak oxygen consumption (VO2), 6-min walk (6 MW), New York Heart Association (NYHA) class, quality of life (QOL), and echocardiographic analysis.
RESULTS: A 15% reduction in HF progression was observed, but this was statistically insignificant (p = 0.35). The CRT, however, significantly improved peak VO2 (0.8 ml/kg/min vs. 0.0 ml/kg/min, p = 0.030) and 6 MW (35 m vs. 15 m, p = 0.043). Changes in NYHA class (p = 0.10) and QOL (p = 0.40) were not statistically significant. The CRT demonstrated significant reductions in ventricular dimensions (left ventricular internal diameter in diastole = 3.4 mm vs. 0.3 mm, p < 0.001 and left ventricular internal diameter in systole = 4.0 mm vs. 0.7 mm, p < 0.001) and improvement in left ventricular ejection fraction (5.1% vs. 2.8%, p = 0.020). A subgroup of patients with advanced HF (NYHA class III/IV) consistently demonstrated improvement across all functional status end points.
CONCLUSIONS: The CRT improved functional status in patients indicated for an ICD who also have symptomatic HF and intraventricular conduction delay.
| ||||||||||||||||||||||||||||
This article has been cited by other articles:
![]() |
T. Stanton, N. M. Hawkins, K. J. Hogg, N. E.R. Goodfield, M. C. Petrie, and J. J.V. McMurray How should we optimize cardiac resynchronization therapy? Eur. Heart J., August 28, 2008; (2008) ehn380v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Buck, A. H. Maass, W. Nieuwland, R. L. Anthonio, D. J. Van Veldhuisen, and I. C. Van Gelder Impact of interventricular lead distance and the decrease in septal-to-lateral delay on response to cardiac resynchronization therapy Europace, August 11, 2008; (2008) eun208v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Marciniak, B Bijnens, A Baltabaeva, A Marciniak, C Parsai, P Claus, and G R Sutherland Interventricular interaction as a possible mechanism for the presence of a biphasic systolic velocity profile in normal left ventricular free walls Heart, August 1, 2008; 94(8): 1058 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Sweeney and F. W. Prinzen Ventricular Pump Function and Pacing: Physiological and Clinical Integration Circ Arrhythmia Electrophysiol, June 1, 2008; 1(2): 127 - 139. [Full Text] [PDF] |
||||
![]() |
L. J. Anderson, C. Miyazaki, G. R. Sutherland, and J. K. Oh Patient Selection and Echocardiographic Assessment of Dyssynchrony in Cardiac Resynchronization Therapy Circulation, April 15, 2008; 117(15): 2009 - 2023. [Full Text] [PDF] |
||||
![]() |
M. M. Borggrefe, T. Lawo, C. Butter, H. Schmidinger, M. Lunati, B. Pieske, A. R. Misier, A. Curnis, D. Bocker, A. Remppis, et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure Eur. Heart J., April 2, 2008; 29(8): 1019 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
J G F Cleland, N Freemantle, J-C Daubert, W D Toff, F Leisch, and L Tavazzi Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study Heart, March 1, 2008; 94(3): 278 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Lin, R F Rea, S C Hammill, D L Hayes, and P A Brady Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices Heart, February 1, 2008; 94(2): 186 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Beshai, R. A. Grimm, S. F. Nagueh, J. H. Baker II, S. L. Beau, S. M. Greenberg, L. A. Pires, P. J. Tchou, and the RethinQ Study Investigators Cardiac-Resynchronization Therapy in Heart Failure with Narrow QRS Complexes N. Engl. J. Med., December 13, 2007; 357(24): 2461 - 2471. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Leclercq, G. B. Bleeker, C. Linde, E. Donal, J. J. Bax, M. J. Schalij, and C. Daubert Cardiac resynchronization therapy: clinical results and evolution of candidate selection Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I94 - I106. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tabrizi, A. Englund, M. Rosenqvist, L. Wallentin, and U. Stenestrand Influence of left bundle branch block on long-term mortality in a population with heart failure Eur. Heart J., October 2, 2007; 28(20): 2449 - 2455. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Europace, October 1, 2007; 9(10): 959 - 998. [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Eur. Heart J., September 2, 2007; 28(18): 2256 - 2295. [Full Text] [PDF] |
||||
![]() |
C Leclercq New guidelines for cardiac resynchronisation therapy: simplicity or complexity for the doctor? Heart, September 1, 2007; 93(9): 1017 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Hohnloser and E. N. Prystowsky CRT-D use in heart failure: too little or too much? Eur. Heart J. Suppl., September 1, 2007; 9(suppl_G): G9 - G16. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. McAlister, J. Ezekowitz, N. Hooton, B. Vandermeer, C. Spooner, D. M. Dryden, R. L. Page, M. A. Hlatky, and B. H. Rowe Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction: A Systematic Review JAMA, June 13, 2007; 297(22): 2502 - 2514. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Burkhardt and B. L. Wilkoff Interventional Electrophysiology and Cardiac Resynchronization Therapy: Delivering Electrical Therapies for Heart Failure Circulation, April 24, 2007; 115(16): 2208 - 2220. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lindenfeld, A. M. Feldman, L. Saxon, J. Boehmer, P. Carson, J. K. Ghali, I. Anand, S. Singh, J. S. Steinberg, B. Jaski, et al. Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure Circulation, January 16, 2007; 115(2): 204 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Badano, O. Gaddi, C. Peraldo, G. Lupi, M. Sitges, F. Parthenakis, S. Molteni, M. R. Pagliuca, B. Sassone, P. Di Stefano, et al. Left ventricular electromechanical delay in patients with heart failure and normal QRS duration and in patients with right and left bundle branch block Europace, January 1, 2007; 9(1): 41 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Saxon, M. R. Bristow, J. Boehmer, S. Krueger, D. A. Kass, T. De Marco, P. Carson, L. DiCarlo, A. M. Feldman, E. Galle, et al. Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial Circulation, December 19, 2006; 114(25): 2766 - 2772. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Abraham Response to Abraham Circulation, December 12, 2006; 114(24): 2692 - 2698. [Full Text] [PDF] |
||||
![]() |
J. A. White, R. Yee, X. Yuan, A. Krahn, A. Skanes, M. Parker, G. Klein, and M. Drangova Delayed Enhancement Magnetic Resonance Imaging Predicts Response to Cardiac Resynchronization Therapy in Patients With Intraventricular Dyssynchrony J. Am. Coll. Cardiol., November 21, 2006; 48(10): 1953 - 1960. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rivero-Ayerza, D. A.M.J. Theuns, H. M. Garcia-Garcia, E. Boersma, M. Simoons, and L. J. Jordaens Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials Eur. Heart J., November 2, 2006; 27(22): 2682 - 2688. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G.F. Cleland, J.-C. Daubert, E. Erdmann, N. Freemantle, D. Gras, L. Kappenberger, L. Tavazzi, and on behalf of The CARE-HF Study Investigators Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Eur. Heart J., August 2, 2006; 27(16): 1928 - 1932. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Jarcho Biventricular pacing. N. Engl. J. Med., July 20, 2006; 355(3): 288 - 294. [Full Text] [PDF] |
||||
![]() |
C. Ermis and D. G. Benditt Cardiac resynchronization pacing without defibrillator capability: is this a viable option? Europace, July 1, 2006; 8(7): 499 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Hawkins, M. C. Petrie, M. R. MacDonald, K. J. Hogg, and J. J.V. McMurray Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony? Eur. Heart J., June 1, 2006; 27(11): 1270 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Donal, C. Leclercq, C. Linde, and J.-C. Daubert Effects of cardiac resynchronization therapy on disease progression in chronic heart failure Eur. Heart J., May 1, 2006; 27(9): 1018 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Goldberger and R. Lampert Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies JAMA, February 15, 2006; 295(7): 809 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. McAlister, J. V. Tu, A. Newman, D. S. Lee, S. Kimber, B. Cujec, and P. W. Armstrong How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts Eur. Heart J., February 1, 2006; 27(3): 323 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. St John Sutton, T. Plappert, K. E. Hilpisch, W. T. Abraham, D. L. Hayes, and E. Chinchoy Sustained Reverse Left Ventricular Structural Remodeling With Cardiac Resynchronization at One Year Is a Function of Etiology: Quantitative Doppler Echocardiographic Evidence From the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Circulation, January 17, 2006; 113(2): 266 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Bax, T. Abraham, S. S. Barold, O. A. Breithardt, J. W.H. Fung, S. Garrigue, J. Gorcsan III, D. L. Hayes, D. A. Kass, J. Knuuti, et al. Cardiac Resynchronization Therapy: Part 2--Issues During and After Device Implantation and Unresolved Questions J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2168 - 2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Ellenbogen, M. A. Wood, and H. U. Klein Why Should We Care About CARE-HF? J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2199 - 2203. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Daubert, C. Leclercq, and P. Mabo There Is Plenty of Room for Cardiac Resynchronization Therapy Devices Without Back-Up Defibrillators in the Electrical Treatment of Heart Failure J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2204 - 2207. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Marcus, E. Rose, E. M. Viloria, J. Schafer, T. De Marco, L. A. Saxon, E. Foster, and for the VENTAK CHF/CONTAK-CD Biventricular Pacing Septal to Posterior Wall Motion Delay Fails to Predict Reverse Remodeling or Clinical Improvement in Patients Undergoing Cardiac Resynchronization Therapy J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2208 - 2214. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ermis, R. Seutter, A. X. Zhu, L. C. Benditt, L. VanHeel, S. Sakaguchi, K. G. Lurie, F. Lu, and D. G. Benditt Impact of Upgrade to Cardiac Resynchronization Therapy on Ventricular Arrhythmia Frequency in Patients With Implantable Cardioverter-Defibrillators J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2258 - 2263. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Feldman, G. de Lissovoy, M. R. Bristow, L. A. Saxon, T. De Marco, D. A. Kass, J. Boehmer, S. Singh, D. J. Whellan, P. Carson, et al. Cost Effectiveness of Cardiac Resynchronization Therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2311 - 2321. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Hlatky Cost Effectiveness of Cardiac Resynchronization Therapy J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2322 - 2324. [Full Text] [PDF] |
||||
![]() |
P. Carson, I. Anand, C. O'Connor, B. Jaski, J. Steinberg, A. Lwin, J. Lindenfeld, J. Ghali, J. H. Barnet, A. M. Feldman, et al. Mode of Death in Advanced Heart Failure: The Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) Trial J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2329 - 2334. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Leon, W. T. Abraham, A. B. Curtis, J. P. Daubert, W. G. Fisher, J. Gurley, D. L. Hayes, R. Lieberman, S. Petersen-Stejskal, K. Wheelan, et al. Safety of Transvenous Cardiac Resynchronization System Implantation in Patients With Chronic Heart Failure: Combined Results of Over 2,000 Patients From a Multicenter Study Program J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2348 - 2356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Calvert, N. Freemantle, G. Yao, J. G.F. Cleland, L. Billingham, J.-C. Daubert, S. Bryan, and on behalf of the CARE-HF Investigators Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial Eur. Heart J., December 2, 2005; 26(24): 2681 - 2688. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Singh, W. J. Hall, S. McNitt, H. Wang, J. P. Daubert, W. Zareba, J. N. Ruskin, A. J. Moss, and and the MADIT-II Investigators Factors Influencing Appropriate Firing of the Implanted Defibrillator for Ventricular Tachycardia/Fibrillation: Findings From the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II) J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1712 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
Developed in Collaboration With the American Colle, Endorsed by the Heart Rhythm Society, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J. Am. Coll. Cardiol., September 20, 2005; 46(6): 1116 - 1143. [Full Text] [PDF] |
||||
![]() |
S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society Circulation, September 20, 2005; 112(12): 1825 - 1852. [Full Text] [PDF] |
||||
![]() |
S. A. Strickberger, J. Conti, E. G. Daoud, E. Havranek, M. R. Mehra, I. L. Pina, J. Young, and Endorsed by the American College of Cardiology Fou Patient Selection for Cardiac Resynchronization Therapy: From the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Heart Rhythm Society Circulation, April 26, 2005; 111(16): 2146 - 2150. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G.F. Cleland, J.-C. Daubert, E. Erdmann, N. Freemantle, D. Gras, L. Kappenberger, L. Tavazzi, and the Cardiac Resynchronization -- Heart Failure (CA The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure N. Engl. J. Med., April 14, 2005; 352(15): 1539 - 1549. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Olsson, K. Swedberg, A. L. Clark, K. K. Witte, and J. G.F. Cleland Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review Eur. Heart J., April 2, 2005; 26(8): 778 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stellbrink Heart rate, regularity, and synchronicity in heart failure: a tale of three brothers Eur. Heart J., April 1, 2005; 26(7): 637 - 638. [Full Text] [PDF] |
||||
![]() |
M. M. Scheinman and E. Keung The year in clinical electrophysiology J. Am. Coll. Cardiol., March 1, 2005; 45(5): 790 - 795. [Full Text] [PDF] |
||||
![]() |
F. A. McAlister, N. Wiebe, and W. Abraham Cardiac Resynchronization Therapy in Heart Failure Ann Intern Med, February 15, 2005; 142(4): 307 - 308. [Full Text] [PDF] |
||||
![]() |
M. Calvert, N. Freemantle, and J. G.F. Cleland Cardiac Resynchronization Therapy in Heart Failure Ann Intern Med, February 15, 2005; 142(4): 305 - 307. [Full Text] [PDF] |
||||
![]() |
W. T. Abraham, J. B. Young, A. R. Leon, S. Adler, A. J. Bank, S. A. Hall, R. Lieberman, L. B. Liem, J. B. O'Connell, J. S. Schroeder, et al. Effects of Cardiac Resynchronization on Disease Progression in Patients With Left Ventricular Systolic Dysfunction, an Indication for an Implantable Cardioverter-Defibrillator, and Mildly Symptomatic Chronic Heart Failure Circulation, November 2, 2004; 110(18): 2864 - 2868. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. McAlister, J. A. Ezekowitz, N. Wiebe, B. Rowe, C. Spooner, E. Crumley, L. Hartling, T. Klassen, and W. Abraham Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure Ann Intern Med, September 7, 2004; 141(5): 381 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P Boehmer CRT only or CRT plus ICD? Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D83 - D87. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stellbrink, O.-A. Breithardt, A.-M. Sinha, and P. Hanrath How to discriminate responders from non-responders to cardiac resynchronisation therapy Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D101 - D105. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Josephson and H. J.J. Wellens Implantable Defibrillators and Sudden Cardiac Death Circulation, June 8, 2004; 109(22): 2685 - 2691. [Full Text] [PDF] |